InsidersTradesSigma
Track the CSPC Pharmaceutical Group Ltd. stock price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares trade on HK HK, under the oversight of HKEX. Operating in the Health Care sector, CSPC Pharmaceutical Group Ltd. has published 6 insider filings. Market capitalisation: €93.1bn. The latest transaction was reported on 29 June 2026 (Sale). Among the most active insiders: Cai Dong Chen. The full history is openly available.
Analysts rate CSPC Pharmaceutical Group Ltd. Buy (bullish), based on 22 analysts. Average price target: HK$11.61.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
CSPC Pharmaceutical Group Ltd. is a China-based pharmaceutical company engaged in the research, development, manufacturing, and marketing of drugs. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.